Clinical Trial

AZA+Lus VS AZA Monotherapy in HR-MDS

Name: AZA+Lus VS AZA Monotherapy in HR-MDS — clinical trial record (NCT06927232)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated April 15, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.

Summary

This study is a randomized, prospective, single-center, open-label cohort study involving untreated HR-MDS patients. The patients were divided randomized into AZA+Lus cohort and AZA monotherapy cohort.

Trial Details

NCT Number	NCT06927232
Lead Sponsor	Peking Union Medical College Hospital
Conditions	Higher-risk Myelodysplastic Syndrome
Enrollment	86 participants
Start Date	2025-04
Primary Completion	2026-01-31 (estimated)
Study Completion	2027-01-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-15